Sir Richard is Chairman of the Royal Institution of Great Britain, Chairman of the UK Stem Cell Foundation, Chairman of CRAC the careers and research advisory council, Chairman of Toumaz, Circassia, Omnicyte, NetScientific and the investment board of Deepridge Capital. He is vice chairman of the Swiss Life Sciences Company Lonza Group and sits on the advisory boards of Siemens Holdings plc and the Virgin Group.

 

Prior to that, he was Senior Independent Director and non executive Chairman of ENRC from 2007 to June 2011, Chairman of NHS London from December 2008 to July 2010, Rector of Imperial College London from 2000 to 2008. He was a none executive director of Rio Tinto plc from 1997 to 2007 and senior independent director from 2004 to 2007 He has over 30 years experience within the biotechnology and pharmaceutical industries, serving as Chief Executive and Chairman of GlaxoWellcome from 1995 to 2000 and then as Chairman of GlaxoSmithkline until 2002.

 

Internationally he is Chairman of the International Advisory Board, A* Star Biomedical Research Council, Singapore and a Board member of EDBI. He was awarded Honorary Citizenship of Singapore in 2004 for his contribution to the development of the country’s biomedical sciences industry.

 

Sir Richard holds a number of degrees and awards from Institutions both in the UK and overseas. He is a Fellow of the Royal Society and Academy of Medical Sciences and an Honorary Fellow of the Royal Academy of Engineeering, Royal Society of Chemistry, Royal Pharmaceutical Society, Royal College of Pathologists and the Royal College of Physicians. He is also President of the R and D Society, a position he has held since 2002.

 

He is a Fellow of Imperial College London and the Imperial College School of Medicine, Kings College London, and Honorary Fellow of the Universities of Wales and Central Lancashire.

 

Sir Richard received a Knighthood in the 1994 New Year’s Honours list for services to the pharmaceutical industry. 

 

 

Back To Top